Home Technology Seminars

Technology Seminar (26 Sep 2016)

Print
Technology Seminar

Illumina's 'Screening Array Program':

A High-powered, Economical Tool for Large

Population Scale Genomics

By

 Dr Carsten Rosenow

Director of Global Sales (Genotyping Products), Illumina, Inc  


26 September 2016 (Mon)

10:00 – 11:30 am  


Seminar Room 1A, G/F
 

The Hong Kong Jockey Club Building for Interdisciplinary Research 

5 Sassoon Road, Pokfulam, Hong Kong

 

 

Abstract:
As human genomics enters the era of big data there is a rise in large global biobanks, DNA repositories and clinical institutions with a breadth of phenotypic data readily available. While these cohorts are not limited by access to phenotype data, budget constraints can hinder their ability to generate relevant genetic data for discovery and analysis using large number of samples. To remedy this limitation and create opportunities for large-scale genomic analysis, Illumina has introduced the “Screening Array Program” with the first products the Multiethnic Global Array and the new Global Screening Array (GSA) which is specifically designed to enable low cost yet powerful, large scale global genotyping programs. Dr Rosenow will discuss how Illumina has partnered with leading global institutions for research, health care, biobanking and consumer genotyping to use its technology and advance personalized medicine and improve health care. Dr Rosenow will also introduce a new Array Screening Consortium specifically for Asian Population studies.

  

Speaker:
Dr Rosenow was awarded a graduate degree in Chemistry and Biochemistry from the Albert Ludwigs University in Freiburg Germany, where he also received his PhD in Chemistry. His scientific work was published in Nature Genetics, The Journal of Infectious Disease, Molecular Microbiology, Nucleic Acid Research, Journal of Bacteriology, Genome Research and others.

In 2006, Dr Rosenow joined Illumina as the senior market manager for their genotyping product portfolio including all array products and instrumentation. He joined the illlumina sales organization in 2010 as the associate director for applied markets and established a global team of sales specialists focused on applied market segments including genotyping, pharmaceutical markets, NIPT and forensics utilising the complete Illumina portfolio including array, sequencing and Dx/IVD products. He is currently the Director of Global Sales for all Genotyping Products.

 
ALL ARE WELCOME

Co-organized with Illumina Hong Kong Ltd Illumina Logo
Refreshment to be served

For enquiries, please call 2831-5500 or write to This e-mail address is being protected from spambots. You need JavaScript enabled to view it